Subscribe to RSS - Alere

Alere

Mail-order market for diabetes on precipice of disaster

As Arriva prepares to close, stakeholders expect increased pressure on an already shaky infrastructure
 - 
11/10/2017

CORAL SPRINGS, Fla. – With Arriva Medical, the largest mail-order supplier of diabetes testing supplies, closing its doors at the end of the year, industry stakeholders predict chaos.

Arriva Medical in ‘midst’ of ALJ appeal

Acquisition by Abbott Laboratories moves forward
 - 
04/21/2017

CORAL SPRINGS, Fla. – Arriva Medical, a provider of diabetes testing supplies, remains confident that it will get its Medicare billing status reinstated.

Abbott Labs, Alere deal moves forward

 - 
04/18/2017

ABBOTT PARK, Ill., and WALTHAM, Mass. – Abbott Laboratories has agreed to buy Alere, but at a lower price than it previously offered.

Arriva gets day in court

 - 
01/11/2017

WALTHAM Mass. – CMS has agreed not to terminate Arriva Medical’s mail-order contract while the provider appeals to have its license reinstated.

In brief: CMS releases nat’l health expenditures, OIG says two brands dominate mail-order market for diabetes supplies

 - 
12/09/2016

WASHINGTON – Per-capita healthcare spending grew by 5% and overall healthcare spending grew by 5.8% in 2015, according to a recent study by the Office of the Actuary at CMS.

Abbott wants to ditch Alere

 - 
12/08/2016

WALTHAM, Mass. – Abbott Laboratories has sued Alere in an effort to terminate its buyout of the company, according to news reports.

CMS revokes Arriva’s billing privileges

 - 
11/22/2016

CORAL SPRINGS, Fla. – Arriva Medical’s contract for CMS’s national mail-order program for diabetes supplies is in question.